# A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures

> **NCT06657378** · — · RECRUITING · sponsor: **Eisai Co., Ltd.** · enrollment: 110 (estimated)

## Conditions studied

- Partial-Onset Seizures
- Primary Generalized Tonic-clonic Seizures

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT06657378
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-18
- **Primary completion:** 2028-06-15
- **Final completion:** 2028-06-15
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2025-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06657378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06657378, "A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06657378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*